Biogen and its rivals

A board to discuss future MS therapies in early stage (Phase I or II) trials.
Post Reply
User avatar
Needled
Family Elder
Posts: 361
Joined: Wed Jan 14, 2009 3:00 pm
Location: Connecticut
Contact:

Biogen and its rivals

Post by Needled »

This article describes a Phase III trial of a new formulation of Avonex taken every two or four weeks and comments on competition with Tysabri and some of the oral meds in trial. Looks like Cladribine and Fingolimod are still on track for FDA filing this year. Novartis releases its first quarter results on April 23, so there should be an update on Fingolimod then as well.

http://www.thestreet.com/story/10477612 ... ivals.html
Post Reply

Return to “Drug Pipeline”